265 strains of multiple drug resistance of Acinetobacter baumannii clinical distribution and drug resistance analysis

Jiahong Guo,Jinghua Zhou,Wensheng Wang,Donghui Yan

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2015.24.003

2015-01-01

Abstract:Objective To understand the multiple drug resistance of Acinetobacter baumannii in clinical distribution and drug resistance characteristics,to guide clinical rational use of Antimicrobial agents.Methods Using biological Merieux API20 NE system for strain identification,using K-B paper method and broth dilution method to carry out drug sensitivity test.Results 2011-2014,there were totally 265 strains of the clinical separation of multiple drug resistant Acinetobacter baumannii,with the highest sputum specimen detection,rating 84.9 ％.Distribution department is mainly for the intensive care unit,respiratory medicine and cardiology,accounted for 51.7 ％,21.1％ and 21.1 ％,respectively.Multiple drug resistant Acinetobacter baumannii of Polymyxin B resistance to a minimum of 2.6％,followed by Tigecycline,Minocycline and Amikacin,6.4％,11.7％,and 13.6％ respectively;The resistant rate of Ceftazidime,Ceftriaxone,Imipenem,Aztreonam,Ampicillin and Ampicillin/Sulbactam reaches more than 80％,and the rest of the Antibiotic resistant rate is between 58.5％ and 79.2％.Conclusions Multiple drug-resistant infections caused by Acinetobacter baumannii is given priority to the respiratory tract,the most serious infection in ICU and respiratory medicine,and it has a high resistance to many kinds of the clinical commonly used antibiotics.We should actively carry out the inspection of pathogeny to guide clinical rational use of antimicrobial agents.